CS logo
small CS logo
Dermatologikum Hamburg

Hamburg, Germany
Dermatologist in Hamburg
Stephanspl. 5, 20354 Hamburg

About Dermatologikum Hamburg


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Incyte Corporation
2
Coherus Biosciences, Inc.
1
HAL Allergy
1
Pierre Fabre Medicament
1
Total Rows: 5

Clinical Trials at Dermatologikum Hamburg


During the past decade, Dermatologikum Hamburg conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11111100221100110000Started TrialsCompleted Trails201920202021202220230123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
2014-06-16
2016-05-12
Completed
521
SUBLIVAC FIX Birch Phase III Short-term Efficacy
2014-09-01
2015-11-01
Completed
406
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
2019-02-12
2020-02-27
Terminated
136
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
2020-06-15
2024-09-30
Active, not recruiting
1,000
Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial
2021-02-16
2022-01-31
Completed
146
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
2023-01-31
2024-09-22
Withdrawn
0
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
2023-01-31
2024-09-22
Withdrawn
0

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Dermatologikum Hamburg" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Coherus Biosciences, Inc." with 1 trials sponsored, "HAL Allergy" with 1 trials sponsored and "Pierre Fabre Medicament" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatologikum Hamburg" #1 collaborator was "Clinact" with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator and "Shire" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 2Eli Lilly and Company: 2Incyte Corporation: 2Incyte Corporation: 2Coherus Biosciences, Inc.: 1Coherus Biosciences, Inc.: 1HAL Allergy: 1HAL Allergy: 1Pierre Fabre Medicament: 1Pierre Fabre Medicament: 1

Created with Highcharts 11.1.0Top CollaboratorsClinact: 1Clinact: 1Dermira, Inc.: 1Dermira, Inc.: 1Shire: 1Shire: 1

Clinical Trials Conditions at Dermatologikum Hamburg


According to Clinical.Site data, the most researched conditions in "Dermatologikum Hamburg" are "Atopic Dermatitis" (2 trials), "Actinic Keratoses" (1 trials), "Birch Pollen Induced Rhinitis/Rhinoconjunctivitis" (1 trials), "Chronic Hand Eczema (CHE)" (1 trials) and "Hand Eczema" (1 trials). Many other conditions were trialed in "Dermatologikum Hamburg" in a lesser frequency.

Clinical Trials Intervention Types at Dermatologikum Hamburg


Most popular intervention types in "Dermatologikum Hamburg" are "Drug" (6 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ruxolitinib cream" (2 trials), "Vehicle" (2 trials), "5-fluorouracil 4% (Tolak)" (1 trials), "CHS-0214" (1 trials) and "Dexeryl" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Dermatologikum Hamburg


The vast majority of trials in "Dermatologikum Hamburg" are 7 trials for "All" genders.

Clinical Trials Status at Dermatologikum Hamburg


Currently, there are NaN active trials in "Dermatologikum Hamburg". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dermatologikum Hamburg, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Dermatologikum Hamburg, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Withdrawn: 2Withdrawn: 2Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1